Indivior Schweiz AG is a specialty pharmaceutical company focused on evidence-based treatment and advancing understanding of opioid use disorder (OUD). It develops and provides therapies, including buprenorphine-based treatments, and conducts research to support long-term recovery.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered4
Treatment of opioid use disorder (OUD)
Evidence-based treatment for opioid use disorder, focusing on long-term recovery, buprenorphine medication-assisted treatment, and patient-centred care.
Medicines for opioid use disorder
Pharmaceutical products for people with opioid use disorder, including long-term treatment options and monthly injectable buprenorphine.
Research and development for addiction medicine
Scientific development of treatment options for opioid use disorder, focusing on long-term care, clinical evidence and scientific leadership.
Advocacy and access to treatment
Collaboration with scientists, clinics, politicians, healthcare systems, judicial institutions and advocacy groups to expand access to evidence-based OUD treatment and reduce stigma.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.